Cellectar Biosciences, Inc.

Cellectar Biosciences is developing phospholipid drug conjugates (PDCs). These monomeric lipid mimetics are designed to provide cancer targeted delivery. We utilize the metabolic change in cancer cells to create the specificity.

Address

Florham Park
New Jersey
United States
Visit website (opens in a new tab)
Loading